Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2022

Sep 22, 2022

32485_dirs_2022-09-22_09fb3f98-71c7-4642-9024-0a72f69f302e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-09-20

Reporting Person: Fox Jennifer A. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-20 Stock option (right to buy) $9.73 A 129370 Acquired 2032-09-20 Class A ordinary share (129370) Direct

Footnotes

F1: The shares underlying the option award vest in three equal annual installments beginning on July 11, 2023, subject to Ms. Fox's continued service as a director of the Company.